Did you know?

82% of pharma firms have been forced to make changes to counter rising energy bills, 36% of which describe the changes as radical.

The pharma industry produces significantly more emissions than the automotive industry.

Pharma produces 48.55 tons of carbon dioxide equivalent (CO2e) for every $1 million USD generated.

Breast Cancer Was The Most Studied Disease Area In 2022

The analysis of 80,917 trial records, from Phesia, reveals that breast cancer retained its position as the moststudied disease area in 2022, followed by COVID-19. Three of the top five most-studied disease areas fell within oncology, with prostate cancer the third moststudied disease, solid tumours fourth, and stroke fifth.

“Oncology remains an area of high investment in clinical development, however, 2022 has seen a widespread scale back of overall activity. The reduction of recruiting trials in the top most-studied disease indications is due to several global factors including the pandemic and the war in Ukraine,” commented Dr Gen Li, president, Phesi. “With an increase in available vaccines and therapies, it is not surprising that the number of recruiting trials for COVID-19 therapies has fallen. However, the reduction in breast cancer trials is unexpected, with 113 fewer recruiting trials in 2022 compared with 2021.”

The analysis has also revealed an increase in Phase II terminations. In 2022, the attrition rate for Phase II clinical trials was 28% – 42% higher than the previous five-year average. This is the highest proportion of terminations at Phase II in recent years and is even higher than in 2020.